|
Real-time Estimate
Cboe BZX
12:04:26 15/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 23.75 USD | -0.13% |
|
+3.58% | -11.31% |
| 19/08 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 07/08 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 1.01B 872M 825M 748M 1.4B 96.64B 1.41B 9.8B 3.77B 49.17B 3.8B 3.72B 155B | P/E 2026 * |
11x | P/E 2027 * | 9.01x |
|---|---|---|---|---|---|
| Enterprise Value | 1.31B 1.13B 1.07B 972M 1.82B 126B 1.83B 12.74B 4.9B 63.91B 4.94B 4.83B 202B | EV / Sales 2026 * |
1.76x | EV / Sales 2027 * | 1.52x |
| Free-Float |
47.23% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
|
Tradegate
| 29A | Real-time | |
|
Deutsche Boerse AG
| 29A | Delayed | |
|
Börse Stuttgart
| 29A | Delayed | |
|
Boerse Muenchen
| 29A | Real-time |
Last Transcript: Amphastar Pharmaceuticals, Inc.
| 1 day | -0.13% | ||
| 1 week | +3.58% | ||
| Current month | +5.42% | ||
| 1 month | +13.58% | ||
| 3 months | +20.50% | ||
| 6 months | +22.36% | ||
| Current year | -11.31% |
| 1 week | 22.3 |  | 24 |
| 1 month | 20.77 | | 24 |
| Current year | 16.64 | | 29.52 |
| 1 year | 16.64 | | 29.52 |
| 3 years | 16.64 | | 65.92 |
| 5 years | 16.64 | | 67.66 |
| 10 years | 12.05 | | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Feng Zhang
CEO | Chief Executive Officer | 79 | 29/02/1996 |
Zi Ping Luo
COO | Chief Operating Officer | 76 | 29/02/1996 |
William Peters
DFI | Director of Finance/CFO | 58 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Zi Ping Luo
CHM | Chairman | 76 | 29/02/1996 |
Yong Feng Zhang
BRD | Director/Board Member | 79 | 29/02/1996 |
William Peters
BRD | Director/Board Member | 58 | 04/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/9/26 | Sell | Chief Technology Officer | -3,187 | 0.0075% | ||
| 11/8/26 | Sell | Director | -7,973 | 0.0181% | ||
| 7/8/26 | Exercice | Chief Financial Officer | 18,286 | 0.0415% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | +3.58% | -12.91% | -49.54% | 1.01B | |
| +1.77% | +0.93% | +51.61% | +91.73% | 994B | |
| +1.41% | +0.15% | +51.93% | +64.60% | 640B | |
| +1.63% | +5.40% | +20.50% | +70.67% | 454B | |
| +5.29% | +3.11% | +40.02% | +40.47% | 337B | |
| +2.14% | -8.39% | +17.69% | +25.99% | 261B | |
| +3.37% | +0.93% | +6.48% | +12.39% | 246B | |
| +0.10% | -3.78% | +37.87% | +44.23% | 204B | |
| +1.63% | -5.94% | -20.81% | -58.82% | 190B | |
| +0.59% | -1.22% | +28.71% | +87.24% | 178B | |
| Average | +1.84% | -4.92% | +22.11% | +32.90% | 350.58B | |
| Weighted average by Cap. | +2.05% | -4.41% | +34.93% | +57.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 748M 644M 610M 553M 1.04B 71.44B 1.04B 7.25B 2.79B 36.34B 2.81B 2.75B 115B | 784M 676M 640M 580M 1.09B 74.94B 1.09B 7.6B 2.92B 38.13B 2.95B 2.88B 120B |
| Net income | 99.32M 85.57M 81.03M 73.44M 138M 9.49B 138M 962M 370M 4.83B 373M 365M 15.25B | 115M 99.45M 94.16M 85.35M 160M 11.03B 161M 1.12B 430M 5.61B 433M 424M 17.73B |
| Net Debt | 303M 261M 248M 224M 421M 28.99B 423M 2.94B 1.13B 14.75B 1.14B 1.11B 46.6B | 184M 159M 150M 136M 255M 17.59B 257M 1.78B 686M 8.95B 692M 676M 28.28B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | USD 23.83 | +0.19% | 18,794 |
| 11/09/26 | USD 23.78 | +1.02% | 410,954 |
| 10/09/26 | USD 23.54 | +2.17% | 514,990 |
| 09/09/26 | USD 23.04 | +0.48% | 351,601 |
| 08/09/26 | USD 22.93 | -1.08% | 460,015 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMPH Stock
Select your edition
All financial news and data tailored to specific country editions
